IJMS | Free Full-Text | Daily Lifestyle and Cutaneous Malignancies
Detecting anti–SARS-CoV-2 antibodies in urine samples: A noninvasive and sensitive way to assay COVID-19 immune conversion | Science Advances
Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences | eLife
JCM | Free Full-Text | Severe COVID-19: Drugs and Clinical Trials
Antibody–Invertase Fusion Protein Enables Quantitative Detection of SARS-CoV-2 Antibodies Using Widely Available Glucometers | Journal of the American Chemical Society
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial - The Lancet Neurology
Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy | British Journal of Cancer
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention - ScienceDirect
Enhanced SARS-CoV-2 neutralization by dimeric IgA | Science Translational Medicine
Publications | Dhanasekaran Lab | Stanford Medicine
Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection | Science Immunology
Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy | Physiological Reviews
Publications | Dhanasekaran Lab | Stanford Medicine
Muscle Toxicity of Drugs: When Drugs Turn Physiology into Pathophysiology | Physiological Reviews
Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences | eLife
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV) | eLife
RAD51B in Familial Breast Cancer | PLOS ONE
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection | Science
Publications | Dhanasekaran Lab | Stanford Medicine
SARS-CoV-2 Antiviral Therapy | Clinical Microbiology Reviews
